Express News | Google To Launch New "Sexual Health & Wellness" Policy On November 11, Permitting Promotion Of Personal Lubricants And Prescription Drugs In Select Countries
GSK Net Profit Expected to Rise, Turnover to Fall -- Earnings Preview
BofA Securities Maintains GlaxoSmithKline(GSK.US) With Sell Rating
Analysts Offer Insights on Healthcare Companies: Insmed (INSM), GlaxoSmithKline (GSK) and Amylyx Pharmaceuticals Inc (AMLX)
Moderna's Stock-Price Target Slashed. It's About Vaccines. -- Barrons.com
Moderna Stock Price Target Slashed. It's About Vaccines. -- Barrons.com
IDEAYA Biosciences Reveals Clearance Of Investigational New DrugApplication With FDA For Initiation Of Phase 1 Clinical Trial To Evaluate Werner Helicase Development Candidate IDE275
It's Time to Get Your Covid and Flu Shots. Everything to Know About This Year's Vaccines. -- Barrons.com
GSK Stays in Red for Seven Straight Sessions
GlaxoSmithKline (GSK) Gets a Sell From J.P. Morgan
Earnings Preview: GSK to Report Financial Results Pre-market on October 30
Unusual Options Activity: WYNN, RJF and Others Attract Market Bets, WYNN V/OI Ratio Reaches 377.5
Just After Pfizer's RSV Vaccine Approval For Younger Adults, GSK Layouts Encouraging Preliminary Data Showing Potential For Use In Larger Population
GSK to Invest Up to $800 Million to Expand Manufacturing Facility in Pennsylvania
Express News | CDC Issues Report On Missouri H5N1 Serology Testing; Confirms No Human-To-Human Transmission Of H5 Bird Flu Detected In US
GSK Reports Fresh Data to Support Expanded Indication for Arexvy
GSK's Arexvy Vaccine Shows Promise for Broader Use
New Data for Arexvy, GSK's Respiratory Syncytial Virus Vaccine, Show Potential to Help Protect a Broader Group of Adults at Increased Risk for RSV Disease
FDA Approves Pfizer's Respiratory Syncytial Virus Vaccine Abrysvo For Adults Below 60 Years
Unusual Options Activity: TEVA, MRVL and Others Attract Market Bets, TEVA V/OI Ratio Reaches 1692.3